Hengrui Europe Therapeutics ^Company

Jiangsu Hengrui Pharmaceuticals is a global pharmaceutical company engaged in the research, development, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, surgical drugs, contrast agents and antibiotics. Hengrui Europe Therapeutics AG is a subsidiary of Hengrui Medicine, China. The company focusses on the clinical research and development of Hengrui’s innovative drugs in Europe.